Advancing ophthalmic drug discovery
Advancing ophthalmic drug discovery
Experimentica Ltd. is a contract research organization (ophthalmic CRO) dedicated to developing and offering novel preclinical ocular models and services to clients in the pharmaceutical, biotech and academic sectors.
We offer the preclinical development pipeline with an industry leading portfolio of in vitro, ex vivo and in vivo models. Choose one of the categories below to learn more:
TESTIMONIALS
-
Thank you for all of your excellent work. I’ve done about 6 or 7 studies with various CRO's over the past year. The breadth of your technical capabilities, scientific expertise, communication, speed, and quality of the report and output far exceeds anything I have received in other collaborations.
Switzerland-based biotech company
-
After discussing dry eye models with several organizations, the expertise at Experimentica stood out head and shoulders above the rest. The care and detail of your model, your insight into the disease and ability to understand our particular mechanism and needs was excellent.
US-based biotech company
-
I wanted to personally thank you for all your help and support over the last two years. We certainly did some great work together, and I look forward to working with you on future projects.
US-based biotech company
-
Experimentica’s team was instrumental in the training of our clinician-scientists by offering internship opportunities and research support. We are impressed by the quality of your work and the in-depth scientific knowledge of your entire team. I look forward to continuing this successful collaboration.
Professor and Chair of Ophthalmology, Academic Medical Center, European Union
LATEST NEWS
Visit our poster in 17th European Congress of Toxicologic Pathology
Experimentica's partner Aiforia Technologies Oy will present joint poster dedicated for illustration of the effectivity of Aflibercept, administered systemically and ... Read More
Welcome to poster session in European Retina Meeting 2019
Experimentica’s poster demonstrating the impact of administered systemically Aflibercept on development of neovascular lesions and capabilities of AI Aiforia® Cloud ... Read More
Let’s meet at European Retina Meeting 2019!
Follow Experimentica Ltd. at the ERM2019, September 12—14, 2019, Helsinki, Finland. If you are attending, be sure to stop by ... Read More
Subscribe to Our Newsletter!
We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy